Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Green Synthesis, Biomedical and Biotechnological Applications of Carbon and Graphene Quantum Dots. a Review Publisher



Iravani S1 ; Varma RS2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Physical Chemistry, Faculty of Science, Regional Centre of Advanced Technologies and Materials, Palacky University in Olomouc, Slechtitelu 27, Olomouc, 783 71, Czech Republic

Source: Environmental Chemistry Letters Published:2020


Abstract

Carbon and graphene quantum dots are prepared using top-down and bottom-up methods. Sustainable synthesis of quantum dots has several advantages such as the use of low-cost and non-toxic raw materials, simple operations, expeditious reactions, renewable resources and straightforward post-processing steps. These nanomaterials are promising for clinical and biomedical sciences, especially in bioimaging, diagnosis, bioanalytical assays and biosensors. Here we review green methods for the fabrication of quantum dots, and biomedical and biotechnological applications. © 2020, Springer Nature Switzerland AG.
Other Related Docs
14. Core-Shell Hybrid Nanoparticles: Production and Application in Agriculture and the Environment, Multifunctional Hybrid Nanomaterials for Sustainable Agri-food and Ecosystems (2020)
16. Marvelous Applications of Quantum Dots, European Review for Medical and Pharmacological Sciences (2013)
17. Biomedical Applications of Lignin-Based Nanoparticles, Nanoparticles and their Biomedical Applications (2020)
37. Nanomaterials and Nanotechnology for Water Treatment: Recent Advances, Inorganic and Nano-Metal Chemistry (2021)
45. Quantum Dots Against Sars-Cov-2: Diagnostic and Therapeutic Potentials, Journal of Chemical Technology and Biotechnology (2022)
48. Nanoparticles As Powerful Tools for Crossing the Blood-Brain Barrier, CNS and Neurological Disorders - Drug Targets (2023)